Clinical Trial Update: Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of L-NMMA in patients with cirrhosis of the liver has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver

Drugs mentioned

• L-NMMA (NG-monomethyl-L-arginine)

Snippet

Sponsor: Regional Hospital Holstebro | Conditions: Liver Cirrhosis | Phase 1 | Status: COMPLETED